George Soros Neurocrine Biosciences Inc Transaction History

Soros Fund Management LLC

$4.01 Billion
Q4 2024

A detailed history of George Soros (Soros Fund Management LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Soros Fund Management LLC holds 200,000 shares of NBIX stock, worth $23.2 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

200,000

Previous 150,000 33.33%

Holding current value

$23.2 Million

Previous $17.3 Million 58.09%

% of portfolio

0.68%

Previous 0.37%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $5.58 Million - $6.97 Million	50,000 Added 33.33%	200,000 $27.3 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $5.13 Million - $6.86 Million	-44,776 Reduced 22.99%	150,000 $17.3 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $4.58 Million - $5.01 Million	35,000 Added 21.91%	194,776 $26.8 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $3.29 Million - $3.63 Million	-25,224 Reduced 13.63%	159,776 $22 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $13.8 Million - $17.3 Million	130,000 Added 236.36%	185,000 $24.4 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $5.17 Million - $6.44 Million	55,000 New	55,000 $6.19 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $661,389 - $876,767	-11,300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $307,008 - $392,192	6,400 Added 130.61%	11,300 $692,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,900	4,900 $225,000

Others Institutions Holding NBIX

# of Institutions

655

Shares Held

95.2M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track George Soros's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.

Account